The toxicological properties of impurities in malathion

Archives of Toxicology

Volumn 42, Issue 2, 1978, Pages 95-106

  Aldridge, W N ^a   Miles, J W ^b   Mount, D L ^b   Verschoyle, R D ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Acetylcholinesterase; Carboxylesterase; Isomalathion; Malathion; Potentiation of toxicity; Trimethyl phosphorothioates

Indexed keywords

ACETYLCHOLINESTERASE; CARBOXYLESTERASE; MALAOXON; MALATHION; PESTICIDE; PHOSPHOROTHIOIC ACID O,O,S TRIMETHYL ESTER;

ANIMAL EXPERIMENT; CENTRAL NERVOUS SYSTEM; DRUG COMPARISON; DRUG TOXICITY; INTOXICATION; ISOMALATHION; NERVOUS SYSTEM; ORAL DRUG ADMINISTRATION; PERIPHERAL NERVOUS SYSTEM; PHOSPHORODITHIOIC ACID O,O,S TRIMETHYL ESTER; PHOSPHORODITHIOIC ACID O,S,S TRIMETHYL ESTER; RAT;

ANIMAL; CHEMISTRY; CRYSTALLIZATION; DRUG CONTAMINATION; FEMALE; LETHAL DOSE 50; MALATHION; RATS;

EID: 0018617380     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/BF00316489     Document Type: Article

References (35)

1. The stereochemistry of asymmetric phosphorus compounds. II. Stereospecificity of the irreversible inactivation of cholinesterase by the enantio-morphs of an organophosphorus inhibitor
2. The absolute configuration of chiral organophosphorus anticholinesterases
3. Malathion A and B-esterases of mouse liver. I. Separation and properties
4. Malathion A and B-esterases of mouse liver. II. Effect of EPN in vitro and in vivo
5. Inhibition of acetylcholinesterase and butyrylcholinesterase by enantiomeric forms of sarin
6. Stereospecificity of hydrolytic enzymes in their reaction with optically active organophosphorus compounds. II. The inhibition of aliesterases, acetylesterases, chymotrypsin and trypsin by S-alkyl p-nitrophenyl methylphosphonothiolates
7. Specificity of substituted phenylphosphorus compounds for esterase inhibition in mice
8. Potentiation and Neurotoxicity induced by certain organophosphates
9. Structure of biologically produced malathion monoacid
10. Comparative potentiation of malathion by triorthotolyl phosphate in four classes of vertebrates
11. Carboxylesterase inhibition as an indicator of malathion potentiation in mice
12. Malathion potentiation and inhibition of hydrolysis of various carboxylic esters by triorthotolylphosphate (TOTP) in mice
13. Malathionase. I. Activity and inhibition
14. Relationship between acute toxicity and in vitro inhibition and hydrolysis of a series of carbalkoxy homologues of malathion
15. Inhibition of acetylcholinesterases by the enantiomers of isopropyl S-2-trimethylammoniumethyl methylphosphonothioate iodide. Affinity and phosphorylation constants
16. Marked potentiation in mammalian toxicity from simultaneous administration of two anticholinesterase compounds
17. Studies on the optically active isomers of O,O-diethyl malathion and O,O-diethylmalaoxon
18. Thiophosphates. VII. Optical active thiophosphates
19. Stereospecific ageing of phosphorylated cholinesterases
20. Hydrolysis of malathion by ali-esterases in vitro and in vivo
21. Kinetics for the inhibition of carboxylesterase by malaoxon
22. Malathion inhibition of esterases as a determinant of malathion toxicity
23. Quantitative measurement of inhibition of the enzymatic detoxification of malathion by EPN (ethyl p-nitrophenyl thionobenzenephosphonate)
24. Stereospecificity of hydrolytic enzymes in their reaction with optically active organophosphorus compounds. I. The reaction of cholinesterase and paraoxonase with S-alkyl p-nitrophenyl methylphosphonothiolates
25. Reaction of organophosphorus compounds with hydrolytic enzymes. III. Inhibition of chymotrypsin and kypsin
26. Potentiation of toxicity of organophosphorus compounds containing carboxyl-ic ester functions toward warm-blooded animals by some organophosphorus impurities
27. A note on glycerol formal as a solvent in toxicity testing
28. “Titration” of acetylcholinesterase with soman
29. Effect of impurities on the mammalian toxicity of technical malathion and acephate
30. Anaesthetic effect produced by organophosphorus compounds
31. Tables for convenient calculation of median-effective dose (LD50 or ED50) and instructions in their use
32. Affinity and phosphorylation constants for the inhibition of cholinesterases by the optical isomers of O-2-butyl S-2 (dimethylammonium) ethyl ethylphosphonothioate hydrogen oxalate